The global preclinical imaging market size was valued at USD 870.4 million in 2021, growing at a CAGR of 7.1% during the forecast period 2022-2028. The research report “Global Preclinical Imaging Market by type of Product (Imaging Modalities, Single Photon emission computed tomography (SPECT), Micro Computed Tomography (Micro-CT), Magnetic Particle Imaging, Magnetic Resonance Imaging (MRI), Optical Imaging, X-Ray Imaging, Positron Emission Tomography (PET), Ultrasound , Reagents and Kits, Others), by Application (Research and Development, Drug Discovery), by End User (Biotech Companies, Pharmaceutical companies, Research institutes), and Geography- Global/Region/Country Forecast to 2028.” The global preclinical imaging market size was estimated at USD 870.4 mn in 2021, growing at CAGR rate of 7.1% during the forthcoming years 2022-2028.
View the detailed Report Description here - https://precisionbusinessinsights.com/market-reports/global-preclinical-imaging-market/
Preclinical imaging is helpful to monitor the treatment regime responses allow to get the early indications of efficacy. It is also used during drug discovery process in live animals. Most important preclinical imaging is targeted for illnesses including neurological disorders, autoimmune diseases, cardiovascular diseases, cancers and others. Technological improvements and advances in in-vivo clinical study offering the novel opportunities for understanding the clearly molecular details level. Increased early diagnosis coupled with growing adoption of sophisticated diagnostic technologies have expected to speed up the market growth.
Increasing number of drug trials because of the increase in the prevalence of chronic illnesses such as neurological disorders, rheumatoid arthritis, cancer and cardiovascular disorders, increasing number of contract research organizations as well as innovations in the devices utilized for small imaging technological developments are fuelling the preclinical imaging market growth. There are a few factors hampering the market growth such as the huge cost of equipment, lack of proper infrastructure and lack of skilled personnel to handle the equipment. In addition, one of the major factors hindering the market growth is the limitations on animal drug testing by animal rights organizations.
Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=16068
North America accounted for significant share in the Preclinical Imaging Market
On the basis of regional analysis, global preclinical imaging market is categorized into major regions such as North America, Latin America, Asia Pacific, Europe, Middle East and Africa. Among all these regions, North America anticipated to witness considerable rates because of the increase in the prevalence of chronic diseases such as cardiovascular disease, growing adoption of novel technologies for better clinical outputs and technological developments. According to the National Cancer Institute, in 2017, about 1,685,210 new cancer cases are estimated to be diagnosed. Europe is anticipated to be another most important market for preclinical imaging because of the crucial factors such as research and development activity to treat and prevent diseases and increase in healthcare consciousness amid people. Asia-Pacific preclinical imaging market anticipated to show profitable growth opportunity because of the favorable government policies coupled with the cost-effective clinical and preclinical imaging services.
Competitive Analysis - Global Preclinical Imaging Market
A few major players working in the global preclinical imaging market are FUJIFILM Holdings Corporation (Japan), MR Solutions (U.K.), PerkinElmer Inc. (U.S.), Siemens Ltd (U.S.), Miltenyi Biotec (Germany), Aspect Imaging (Canada), MILabs B.V. (Netherlands) and Bruker Corporation (U.S.).
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Precision Business Insights | Toll Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747